LVMH Market Value Exceeds $500B; First European Company To Hit The Milestone
LVMH-Moet Hennessy Louis Vuitton (OTC: LVMHF), the French fashion giant, has become the first European company to surpass the $500 billion market value.
Investors Underestimate Power Of This Pieced Flywheel: Analyst Kicks Off Coverage On CVS Health
As a part of a broader coverage of 15 companies in the Healthcare Services sector, Cantor Fitzgerald initiated coverage on CVS…
Bargain Hunters, Rejoice: Analyst Unveils Undervalued Humana Stock, Kicks Off Coverage
Cantor Fitzgerald initiated coverage on 15 companies in the Healthcare Services sector. The analysts have a favorable view of payors, acute, outpatient, FemTech, brick-and-mortar alternatives, and opioid abuse treatment centers.
HCA Healthcare Is On Path To ‘Multi-Year Margin Expansion’: Bullish Analyst Shows Confidence
Cantor Fitzgerald initiated coverage on HCA Healthcare Inc (NYSE: HCA) under a broader coverage of 15 companies in the Healthcare Services sector.
Risk-Radar Alert: Analyst Acknowledges Cigna’s Unrecognized Market Risk Hedge, Bestows Neutral Stance
As a part of a broader coverage of 15 companies in the Healthcare Services sector, Cantor Fitzgerald initiated coverage on Cigna…
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
Incyte Corporation (NASDAQ: INCY) will report Q1 FY23 results on May 2.
Investor focus remains on the Opzelura launch, which has faced some hiccups over the first 18 months of launch and began to gain traction toward the end of 2022.
Will US Medicare Fully Cover Alzheimer’s Drugs? Eli Lilly Thinks Yes!
Eli Lilly And Co (NYSE: LLY) expects the U.S. Medicare health plan to loosen its grip on the coverage limits on new Alzheimer's drugs, as more data emerging in coming weeks show that clearing amyloid brain plaques can help patients.
Carlyle Seeks New Investors For McDonald’s China Arm, US Judge Halts Several Johnson & Johnson’s Talc-Related Lawsuits, A Look At How Much Alphabet Analysts, Managers And Engineers Get Paid: Today’s Top Stories
Bloomberg
Carlyle Seeks New Investors For McDonald's $10B China Arm
Why HCA Healthcare Shares Are Trading Higher Today
HCA Healthcare Inc (NYSE:HCA) has reported Q1 FY23 revenues of $15.59 billion, compared to $14.94 billion a year ago, missing…
US Judge Halts Several Lawsuits Related To Johnson & Johnson’s Talc Products Caused Cancer
A federal bankruptcy judge Michael Kaplan temporarily held around 38,000 lawsuits alleging Johnson & Johnson's (NYSE: JNJ) baby powder and other talc products caused cancer as a part of J&J's second attempt to settle thousands of talc cases in bankruptcy proceedings.